Article
Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients.
PloS one - 1 Jan 2016
Robinson-Cohen Cassianne, Newitt Richard, Shen Danny D, Rettie Allan E, Kestenbaum Bryan R, Himmelfarb Jonathan, Yeung Catherine K
Abstract excerpt
Elevated levels of circulating pro-atherogenic uremic solutes, particularly trimethylamine N-oxide (TMAO), have been implicated in cardiovascular disease development in patients with chronic kidney disease (CKD). TMAO is generated from trimethylamine (TMA) via metabolism by hepatic flavin-containing monooxygenase isoform 3 (FMO3). We determined the functional effects of three common FMO3 variants at amino acids...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
